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Summary An interesting and not previously reported parallel has been observed between the known pattern
of ABO (H) blood group isoantigen expression in normal and neoplastic colonic epithelium and that in the
thyroid. Epithelial expression of blood group isoantigens was not observed in 16 specimens of normal or non-
neoplastic thyroid tissue. This contrasts with the progressive re-expression of these antigens in neoplastic
thyroid tissue. Blood group isoantigens were detected in two of eight papillary a7denomas and 13 of 17
papillary carcinomas. Antigen expression was in part related to differentiation, and stained cells were less
readily detected in follicular tumours, only one of five adenomas and two of seven carcinomas displaying
blood group antigens while three medullary and two anaplastic carcinomas were antigen-deficient.
Normal epithelial cells do not share a common
pattern of blood group isoantigen (BGI) expression.
Szulman has established that during foetal develop-
ment ABO BGI expression varies not only between
organs but also with the developmental age of the
foetus (Szulman, 1960, 1962, 1964). In the distal
colon for example BGIs are readily detected to the
60mm Crown-Rump (CR) stage of development
but then are progressively lost and are absent from
the adult distal colonic epithelium (Szulman, 1960;
Denk et al., 1974). The development of neoplasia
within the distal colon results in a partial re-
expression of ABO BGIs (Denk et al., 1974, 1975).
Epithelial derived endocrine structures display a
similar pattern of foetal antigen expression to that
seen in the distal colon. In the earliest develop-
mental stages of the thyroid the parenchyma has
been shown to readily demonstrate epithelial cell
wall BGIs. These wane at the 70-80mm CR stage,
the gland losing these antigens by the time the final
adult histological structure is obtained (Szulman,
1964). Both Holborow and associates (1960) and
Davidsohn and Stejskal (1972) have shown that
BGIs are absent from the epithelial cells of adult
thyroid acini. A similar pattern has been demon-
strated in the adrenal and parathyroid glands
(Holborow et al., 1960; Szulman, 1964).
The effect of malignant transformation on BGI
expression by endocrine derived epithelial cells has
not, as far as we are aware, been studied. To
investigate the possibility that the pattern of antigen
expression already established for distal colonic
epithelium holds true for thyroid derived epithelium
we have examined a series of normal, benign and
malignant thyroid specimens for BGI expression.
Materials and methods
Histological material
The Pathology Department Addenbrooke's
Hospital Cambridge kindly provided the histological
material for this study. Formalin-fixed paraffin-
embedded blocks of thyroid tissue were obtained
from the archives. The patient's ABO blood group
and the histological classification of the material
examined are detailed in Table I. Serial sections
(5gm) were cut from each block and stained using
a standard indirect immunoperoxidase method out-
lined below.
Table I Histological grading of material and blood
groups of specimens examined
Blood group
Tissue specimens A B AB 0 Total
Normal 4 1 0 3 8
Hyperthyroidism 2 0 0 2 4
Hypothyroidism 2 1 0 1 4
Papillary adenoma 3 2 0 3 8
Follicular adenoma 2 0 0 3 5
Papillary carcinoma 7 2 0 8 17
Follicular carcinoma 3 1 0 3 7
Medullary carcinoma 2 0 0 1 3
Anaplastic carcinoma 2 0 0 0 2
Monoclonal antibodies
Four blood group specific mouse derived mono-
clonal antibodies (McAbs) were used in the study
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(A15/3D3.92.1 - anti-A; NB1/19.112.28 - anti-B;
102 anti-H; F-3 - anti-Y). A15/3D3.92.1 and
NB1/19.112.28 McAbs were obtained from the
MRC Laboratory of Molecular Biology,
Cambridge. The specificities of these McAbs and
their use as immunohistochemical reagents has been
reported elsewhere (Voak et al., 1982; Lowe et al.,
1983; Finan et al., 1983). 102 McAb was kindly
provided by Dr Pastan (Laboratory of Molecular
Biology, National Cancer Institute, Bethesda,
Maryland, USA). The characterisation of this
McAb has shown that it binds specifically to a
Type 2H structure (Fredman et al., 1983; Richert et
al., 1983). F-3 McAb which has been shown to have
specificity for the difucosyl Type 2H structure, the
Y antigen (Lloyd et al., 1983), was kindly provided
by Dr K.O. Lloyd (Memorial Sloan-Kettering
Cancer Centre, New York). We have previously
reported the use of both 102 and F-3 McAbs in the
immunohistochemical localization of the H and Y
blood group antigens (Vowden et al., 1986a,b).
These McAbs were employed as the first layer
reagent in a standard indirect immunoperoxidase
staining technique. Optimal dilutions for each
McAb have already been established (Vowden et
al., 1986a). All McAbs contained 0.1% azide and
were stored at -20°C. McAbs in current use were
held at 4°C.
Immunoperoxidase technique
The use of McAbs in immunoperoxidase techniques
is well established, the method employed in the
current study having been described by Finan et al.
(1982). Briefly, after exposing sections to the prob-
ing McAb or a control solution (see Vowden et al.,
1986a), a rabbit anti-mouse peroxidase conjugate
(Miles Yeda Ltd.) was applied as the second layer.
Binding sites were localized with diaminobenzidine
and hydrogen peroxide and the slides counter
stained with dilute Mayer's haemalum. All speci-
mens were screened for the expression of A, B, H
and Y antigens.
Results
Table II details the staining results obtained. Epi-
thelial cells from the acini of normal thyroid failed
to stain for ABO BGIs although the endothelial
cells and erythrocytes clearly showed expression of
the appropriate ABO isoantigens (Figure 1). The
epithelial component of normal glandular elements
at the periphery of neoplastic tissue and the thyroid
epithelial cells from the eight specimens showing
the characteristic histological changes of hypo and
hyperthyroidism were similarly found to be BGI
deficient.
Of the eight papillary adenomas two displayed
weak epithelial expression of BGIs, one of the three
group A specimens staining with A15 and F-3
McAbs, while one of the group 0 tumours dis-
played weak and patchy staining of isolated
epithelial cells with 102 and F-3 McAbs. Of the five
follicular adenomas examined only one, a group A
specimen, showed evidence of BGI expression there
being low intensity localized staining of isolated
cells with F-3 and 102 McAbs but no staining with
A15 McAb.
In the malignant thyroid tumours BGI expression
was more readily detected. Of 17 papillary car-
cinomas some or all epithelial tumour cells were
found to stain for BGIs in 13 specimens, invasive
and non-invasive components of the same tumour
showing a similar pattern of antigen expression
though the invasive elements tended to display
more generalised intracytoplasmic staining
(Figure 2). Eight tumours showed intense staining
of the luminal boarder of all epithelial cells
(Figure 3). The remaining five specimens exhibited
Table II Staining characteristics of the various histological types of thyroid tissue examined
Group A Group B Group 0
Histology A15 NBJ 102 F-3 A15 NBI 102 F-3 A15 NBJ 102 F-3
Normal thyroid 0/4 0/4 0/4 0/4 0/1 0/1 0/1 0/1 0/3 0/3 0/3 0/3
Normal thyroida 0/19 0/19 0/19 0/19 0/5 0/5 0/5 0/5 0/18 0/18 0/18 0/18
Hyperthyroidism 0/2 0/2 0/2 0/2 - - - 0/2 0/2 0/2 0/2
Hypothyroidism 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1
Papillary adenoma 1/3 0/3 0/3 1/3 0/2 0/2 0/2 0/2 0/3 0/3 1/3 1/3
Follicular adenoma 0/2 0/2 1/2 1/2 - - - 0/3 0/3 0/3 0/3
Papillary carcinoma 5/7 0/7 7/7 7/7 0/2 1/2 1/2 1/2 0/8 0/8 5/8 5/8
Follicular carcinoma 1/3 0/3 1/3 1/3 0/1 0/1 0/1 0/1 0/3 0/3 1/3 1/3
Others 0/4 0/4 0/4 0/4 - 0/1 0/1 0/1 0/1
aRefers tonormalthyroidtissuefound attheperiphery ofabenign ormalignant tumour. Number:x/ywhere x =no.
specimens staining and y=no. specimens examined.ABH ISOANTIGENS AND THE THYROID 723
Figure 1 Section from a group A specimen showing
normal thyroid stained with A15/3D3.92.1 McAb.
Note the absence of staining of thyroid epithelium but
the positive (brown) staining of both endothelium and
erythrocytes. Section counterstained with haemalum.
(x250)
Figure 2 Section from a group 0 papillary adeno-
carcinoma stained with F-3 McAb. Note both the
intense staining of luminal boarder cells and the
weaker but more generalised intracytoplasmic staining
of invasive elements of the tumour. ( x 200)
Figure 3 Section from a group A papillary adeno-
carcinoma stained with 102 McAb. Note again the
staining of the luminal aspect of all epithelial cells.
( x 180)
staining of the luminal boarder of isolated cells, this
pattern being most marked in the less well differ-
entiated tumours. Of the seven group A specimens
five expressed the A antigen while all seven stained
with F-3 and 102 McAbs indicating that both the
H and Y antigens were present. Only two group B
tumours were examined; one of these stained with
NB1, F-3 and 102 McAbs. The other remained
antigen deficient. The eight group 0 tumours failed
to stain with either the anti-A or anti-B McAbs.
Five group 0 tumours were, however, found to
express both the H and Y isoantigens.
Of the seven follicular carcinomas examined only
two displayed staining of isolated epithelial cells.
One group A tumour showing staining in the same
small area with A15, F-3 and 102 McAbs, and one
group 0 tumour stained weakly with F-3 and 102
McAb. Epithelial cells within the three medullary
and two anaplastic tumours were BGI deficient.
Discussion
Although the pattern of BGI expression by normal
endocrine epithelial cells has been well documented
little or nothing is known of the distribution of
ABO antigens by neoplastic endocrine tissue. The
present study has confirmed that normal thyroid
tissue, whether from a normal gland or associated
with a neoplasm, is A, B, H and Y BGI deficient
and has shown that this state persists in both hypo-
and hyperthyroidism. Thyroid adenomas, though
generally antigen deficient, did in three of 13 cases
show evidence of BGIs. This forms an interesting
parallel with the situation in the descending colon
and rectum. This organ displays the same pattern
of blood group antigen deletion during late
embryological development (Szulman, 1964) and
also shows a progressive re-acquisition of BGI by
benign adenomatous polyps (Denk et al., 1975;
Cooper et al., 1980; Vowden et al., 1984). This
parallel is even more remarkable when the ABO
antigen status ofmalignant tumours from both sites
is compared. Several groups have established that
over 50% of distal colonic tumours may re-acquire
A, B and H BGIs (Denk et al., 1974, Cooper &
Haesler 1978; Wiley et al., 1981). In the present
study 13 of 17 (76%) papillary carcinomas and two
of seven (29%) follicular carcinomas were found to
express BGIs. Why BGIs should be more readily
detected in papillary tumours was not apparent.
The re-acquisition of A and B BGIs by some
tumours may be taken as indirect evidence for the
presence of a functional A and B glycosyl trans-
ferase. This contrasts with findings in the breast
and prostate where antigen expression by malignant724 P. VOWDEN et al.
epithelium, as revealed by immunohistochemical
techniques, appears limited to the re-expression of
the H and Y isoantigens (Vowden et al., 1986a,b).
This may suggest a deficiency of A and B glycosyl
transferases in these tumours.
The mechanism by which this change in antigen
expression occurs has not been clearly defined.
Hakomori (1981) has established that dramatic
changes in cellular glycolipid composition and
metabolism are associated with the oncogenic and
ontogenic processes. Alternatively these changes
may reflect alterations in the carbohydrate moieties
of glycoproteins (Picard & Feizi, 1984). It would
seem likely that variations in BGI expression repre-
sent a combination of these factors. It is equally
clear that no one pattern of BGI expression exists.
With malignant transformation the distal colon and
thyroid show a partial re-acquisition of A, B and H
BGIs, the breast and prostate while losing A and B
BGIs totally, tend to retain H isoantigen and the
stomach and urinary bladder shows a partial loss of
all BGIs (Finan et al., 1982, 1983). These findings
would seem to offer some support to the suggestion
that malignant cells may be regarded as cells held
in some phase of their embryological development
(Nowell, 1976). The pattern of malignant epithelial
cell blood group antigen expression does show a
remarkable parallel with those found by Szulman in
his studies on embryological tissues (Szulman, 1960,
1962, 1964).
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